These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 1289355

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE, Olsson-Liljequist B.
    Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
    [Abstract] [Full Text] [Related]

  • 24. [Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].
    Rezvan SP, Sidorenko SV, Budanov SV.
    Antibiot Khimioter; 1995 Apr; 40(4):25-9. PubMed ID: 7654095
    [Abstract] [Full Text] [Related]

  • 25. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
    Alados JC, Martínez-Brocal A, Miranda C, Rojo MD, García V, Domínguez MC, de la Rosa M.
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621
    [Abstract] [Full Text] [Related]

  • 26. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L, Castello L, Di Martino A, Greco G, Legaria MC, Litterio M, Predari SC, Rollet R, Rossetti A, Carloni G, Sarchi MI, Bianchini H.
    Rev Argent Microbiol; 2007 Apr; 39(3):156-60. PubMed ID: 17987852
    [Abstract] [Full Text] [Related]

  • 27. [The sensitivity of anaerobic bacteria to chemotherapeutic agents (Zurich, 1991)].
    Wüst J, Hardegger U.
    Schweiz Rundsch Med Prax; 1991 Dec 27; 80(52):1474-80. PubMed ID: 1815309
    [Abstract] [Full Text] [Related]

  • 28. Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents.
    Clark RB, Bartelt MA, Chan EL, Dalton HP.
    J Antimicrob Chemother; 1992 Jan 27; 29(1):57-67. PubMed ID: 1737725
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection.
    Pelak BA, Citron DM, Motyl M, Goldstein EJ, Woods GL, Teppler H.
    J Antimicrob Chemother; 2002 Nov 27; 50(5):735-41. PubMed ID: 12407133
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities].
    Doğan M, Baysal B.
    Mikrobiyol Bul; 2010 Apr 27; 44(2):211-9. PubMed ID: 20549955
    [Abstract] [Full Text] [Related]

  • 37. [Susceptibility of strict anaerobic bacteria to antibiotics in France: a multicenter study].
    Grollier G, Mory F, Quentin C, Girard-Pipau F, Tigaud S, Sedallian A, Dubreuil L.
    Pathol Biol (Paris); 1994 May 27; 42(5):498-504. PubMed ID: 7824321
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
    Litterio M, Bianchini H, Carloni G, Di Martino A, Fernández Canigia L, Greco G, Legaria C, Rollet R, Rossetti A, Predari SC, Castello L.
    Rev Argent Microbiol; 2004 May 27; 36(3):130-5. PubMed ID: 15559195
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.